Management Team

Riikka Havunen

PhD, VP Operations

VP Operations, Riikka Havunen, has over a decade’s experience on oncolytic viruses and cancer immunotherapy. Riikka had a key role in development of TILT-123, which was the focus of her PhD. Riikka heads Tiltbio’s Quality Affairs and is responsible for maintaining and developing the company’s Quality Management System, which she built on the basis of ISO9001. Riikka is a multitalented expert in CMC and participates also in preclinical strategy planning and other business operations.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Aino Kalervo

MSc, MS, Chief Operating Officer

John Goldfinch

MBA, CRM, US Clinical Lead & CEO - TILT Biotherapeutics LLC

Suvi Sorsa

PhD, VP Clinical Affairs

Víctor Cervera-Carrascón

PhD, VP Scientific Affairs and External Strategy

Hanna Kirk

MSc, VP Product Development